Multiplikator Forward P/S: Sintx Technologies Inc (SINT)
The forward P/S trajectory of Sintx Technologies (SINT) demonstrates restrained market optimism, with the metric holding around 3.20. The company's own plant in Utah serves as the foundation, guaranteeing the quality of its bioceramics. Robotic high-precision implant processing ensures exceptional microscopic accuracy. Business stability is bolstered by a staff of rare materials science experts, which securely protects the internal engineering developments of Sintx Technologies (SINT).
Ringkesan rincian data analitis sintx.com (SINT)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Sintx Technologies|SINT - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Sintx Technologies, Inc.|SINT - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku SINT|SINT - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Sintx Technologies|Rasio cepet sintx.com
- rincian asil keuangan lan kelipatan valuasi:
SINT - Penghasilan resik perusahaan|Bathi sing dikarepake Sintx Technologies|SINT - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Sintx Technologies, Inc.|SINT - Pangali PEG|Pangali EV/EBITDA SINT|SINT - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Sintx Technologies|SINT - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan sintx.com|SINT - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Sintx Technologies
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:SINT (SINTX Technologies)
Sintx Technologies' specialization in creating high-tech medical ceramics requires colossal R&D expenditures, making revenue a key indicator of business scaling. This metric correlates the company's current market value with expected sales volume, reflecting the degree of market optimism priced in. By analyzing the forward price-to-sales valuation trend, an investor can determine whether the company's future successes in biomaterials are overvalued.
Karo sapa Sintx Technologies saingan
Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Corp ATEC|Multiplikator Forward P/S AORT (Artivion, Inc.)|Multiplikator Forward P/S enovis.com ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|BBNX (Beta Bionics Corp) - Multiplikator forward rega marang pendapatan|IRADIMED Inc. - Rega forward marang dodolan|EMBC (Embecta Corp.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep tandemdiabetes.com TNDM|Rasio rega marang prakiraan pendapatan Axogen (AXGN)|SI-BONE Inc (SIBN) - Prakiraan rega marang pendapatan|Orthofix International - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Bioventus Global BVS|OrthoPediatrics Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake treace.com TMCI|Strata Critical Medical (SRTA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CARL (Carlsmed, Inc.)|Rasio rega marang prakiraan pendapatan RxSight Corp|Multiplikator forward rega marang pendapatan ClearPoint (CLPT)|Multiplikator Forward P/S STXS|STIM - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Sight Sciences SGHT|OBIO: Kapitalisasi marang prakiraan pendapatan|ANIK: Multiplikator forward rega marang pendapatan|InspireMD Inc. - Rasio rega marang pendapatan sing dikarepake|zhjmedical.com (ZJYL) - Rasio rega marang prakiraan pendapatan|VANI - Rasio kapitalisasi marang dodolan sing dikarepake|XTNT (Xtant Medical Holdings, Inc.) - Multiplikator Forward P/S|NeuroOne (NMTC) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Modular Medical (MODD)|Myomo Inc - Kapitalisasi marang prakiraan pendapatan|Envoy Medical, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake VVOS (vivoslife.com)|NVNO: Multiplikator forward rega marang pendapatan|TNON (Tenon Medical Inc.) - Kapitalisasi marang prakiraan pendapatan|LFWD (ReWalk Robotics Ltd) - Multiplikator forward rega marang pendapatan|Autonomix Medical - Rega forward marang dodolan|Multiplikator forward rega marang pendapatan IVF|BBLG (bonebiologics.com) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S AXNX|BIOL - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S DYNT (Dynatronics)|FNA - Multiplikator forward rega marang pendapatan|INVO Bio - Multiplikator Forward P/S
